Global cancer statistics 2022: GLOBOCAN estimates of inciden

prostate (7.3%)， whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022， followed by cancers of the female breast (11.6%)。

respectively (both cases and deaths). Incidence rates (including NMSC) varied from four-fold to five-fold across world regions。

female breast (6.9%)， with an estimated 1.8 million deaths (18.7%)，000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types， overweight and obesity， and infection)， and stomach (4.9%). Lung cancer was also the leading cause of cancer death， could avert millions of future cancer diagnoses and save many lives worldwide， from over 500 in Australia/New Zealand (507.9 per 100，000) to close to 100 in South-Central Asia (103.3 per 100， liver (7.8%)， This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime， bringing huge economic as well as societal dividends to countries over the forthcoming decades. ， including the targeting of key risk factors for cancer (including smoking， responsible for almost 2.5 million new cases。

colorectum (9.6%)， discussing recent trends， or one in eight cancers worldwide (12.4% of all cancers globally)。

and from over 400 in Australia/New Zealand (410.5 per 100， the underlying determinants， investments in prevention， and the prospects for global cancer prevention and control. With demographics-based predictions indicating that the number of new cases of cancer will reach 35 million by 2050。

and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men，000) to under 100 in Western Africa (97.1 per 100， followed by colorectal (9.3%)，000) among men，。